147 related articles for article (PubMed ID: 25601198)
1. Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing.
Palo M; Kolakovic R; Laaksonen T; Määttänen A; Genina N; Salonen J; Peltonen J; Sandler N
Int J Pharm; 2015 Oct; 494(2):603-610. PubMed ID: 25601198
[TBL] [Abstract][Full Text] [Related]
2. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
3. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
Azad M; Arteaga C; Abdelmalek B; Davé R; Bilgili E
Drug Dev Ind Pharm; 2015; 41(10):1617-31. PubMed ID: 25347144
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle agglomerates of indomethacin: The role of poloxamers and matrix former on their dissolution and aerosolisation efficiency.
Malamatari M; Somavarapu S; Bloxham M; Buckton G
Int J Pharm; 2015 Nov; 495(1):516-526. PubMed ID: 26364709
[TBL] [Abstract][Full Text] [Related]
5. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution.
He W; Lu Y; Qi J; Chen L; Yin L; Wu W
Int J Nanomedicine; 2013; 8():3119-28. PubMed ID: 23983465
[TBL] [Abstract][Full Text] [Related]
6. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
[TBL] [Abstract][Full Text] [Related]
8. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
10. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
11. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.
Van Eerdenbrugh B; Vercruysse S; Martens JA; Vermant J; Froyen L; Van Humbeeck J; Van den Mooter G; Augustijns P
Eur J Pharm Biopharm; 2008 Oct; 70(2):590-6. PubMed ID: 18602992
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
13. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
[TBL] [Abstract][Full Text] [Related]
14. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
15. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
17. Preparation of azithromycin nanosuspensions by reactive precipitation method.
Hou CD; Wang JX; Le Y; Zou HK; Zhao H
Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
[TBL] [Abstract][Full Text] [Related]
18. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques.
Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N
Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482
[TBL] [Abstract][Full Text] [Related]
19. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening.
Verma S; Kumar S; Gokhale R; Burgess DJ
Int J Pharm; 2011 Mar; 406(1-2):145-52. PubMed ID: 21185926
[TBL] [Abstract][Full Text] [Related]
20. Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.
Laaksonen T; Liu P; Rahikkala A; Peltonen L; Kauppinen EI; Hirvonen J; Järvinen K; Raula J
Pharm Res; 2011 Oct; 28(10):2403-11. PubMed ID: 21537875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]